157 related articles for article (PubMed ID: 31795552)
21. An immunocytochemical study of cytokeratin expression in human middle ear cholesteatoma.
Chao WY; Huang CC
Arch Otorhinolaryngol; 1989; 246(1):37-42. PubMed ID: 2472127
[TBL] [Abstract][Full Text] [Related]
22. The role of inhibitor of DNA-binding (Id1) in hyperproliferation of keratinocytes: the pathological basis for middle ear cholesteatoma from chronic otitis media.
Hamajima Y; Komori M; Preciado DA; Choo DI; Moribe K; Murakami S; Ondrey FG; Lin J
Cell Prolif; 2010 Oct; 43(5):457-63. PubMed ID: 20887552
[TBL] [Abstract][Full Text] [Related]
23. Stem cells in middle ear cholesteatoma contribute to its pathogenesis.
Nagel J; Wöllner S; Schürmann M; Brotzmann V; Müller J; Greiner JF; Goon P; Kaltschmidt B; Kaltschmidt C; Sudhoff H
Sci Rep; 2018 Apr; 8(1):6204. PubMed ID: 29670222
[TBL] [Abstract][Full Text] [Related]
24. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.
Sasaki H; Huang CC
Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-21 promotes the proliferation and invasion of cholesteatoma keratinocytes.
Chen X; Li X; Qin Z
Acta Otolaryngol; 2016 Dec; 136(12):1261-1266. PubMed ID: 27376830
[TBL] [Abstract][Full Text] [Related]
26. Keratinocyte growth factor signaling promotes stem/progenitor cell proliferation under p63 expression during middle ear cholesteatoma formation.
Yamamoto-Fukuda T; Akiyama N
Curr Opin Otolaryngol Head Neck Surg; 2020 Oct; 28(5):291-295. PubMed ID: 32796271
[TBL] [Abstract][Full Text] [Related]
27. Expression of bone morphogenetic protein-2 messenger ribonucleic acid in cholesteatoma fibroblasts.
Schmidt M; Schler G; Gruensfelder P; Hoppe F
Otol Neurotol; 2002 May; 23(3):267-70. PubMed ID: 11981380
[TBL] [Abstract][Full Text] [Related]
28. Platelet-derived growth factor in middle ear cholesteatoma.
Fujioka O; Huang CC
Eur Arch Otorhinolaryngol; 1994; 251(4):199-204. PubMed ID: 7917251
[TBL] [Abstract][Full Text] [Related]
29. [New immunobiologic trends concerning etiopathogenicity of cholesteatoma].
Bujía J
An Otorrinolaringol Ibero Am; 1994; 21(2):199-206. PubMed ID: 7516122
[TBL] [Abstract][Full Text] [Related]
30. Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes.
Vennix PP; Kuijpers W; Peters TA; Tonnaer EL; Ramaekers FC
Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):825-32. PubMed ID: 8703383
[TBL] [Abstract][Full Text] [Related]
31. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
[TBL] [Abstract][Full Text] [Related]
32. [Expression of hypoxia-inducible factor-1alpha in middle ear cholesteatoma].
Liu Y; Cui Y; Yu L; Zhang P
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jan; 19(1):4-6. PubMed ID: 15830692
[TBL] [Abstract][Full Text] [Related]
33. Keratinocyte Growth Factor (KGF) Modulates Epidermal Progenitor Cell Kinetics through Activation of p63 in Middle Ear Cholesteatoma.
Yamamoto-Fukuda T; Akiyama N; Takahashi M; Kojima H
J Assoc Res Otolaryngol; 2018 Jun; 19(3):223-241. PubMed ID: 29549594
[TBL] [Abstract][Full Text] [Related]
34. Expression of PTHrP and RANKL in acquired middle ear cholesteatoma epithelium.
Xie S; Pan Z; Yin T; Ren J; Liu W
Acta Otolaryngol; 2020 May; 140(5):351-355. PubMed ID: 32108533
[No Abstract] [Full Text] [Related]
35. L1CAM-ILK-YAP Mechanotransduction Drives Proliferative Activity of Epithelial Cells in Middle Ear Cholesteatoma.
Yamamoto-Fukuda T; Akiyama N; Kojima H
Am J Pathol; 2020 Aug; 190(8):1667-1679. PubMed ID: 32360569
[TBL] [Abstract][Full Text] [Related]
36. Possible participation of acidic pH in bone resorption in middle ear cholesteatoma.
Nguyen KH; Suzuki H; Ohbuchi T; Wakasugi T; Koizumi H; Hashida K; Baba R; Morimoto H; Doi Y
Laryngoscope; 2014 Jan; 124(1):245-50. PubMed ID: 24122656
[TBL] [Abstract][Full Text] [Related]
37. Increased proliferation and migration of epithelium in advancing experimental cholesteatomas.
Kim HJ; Tinling SP; Chole RA
Otol Neurotol; 2002 Nov; 23(6):840-4. PubMed ID: 12438843
[TBL] [Abstract][Full Text] [Related]
38. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
Raynov AM; Moon SK; Choung YH; Hong SP; Park K
Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
[TBL] [Abstract][Full Text] [Related]
39. Identification of Id1 in acquired middle ear cholesteatoma.
Zhang QA; Hamajima Y; Zhang Q; Lin J
Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):306-10. PubMed ID: 18347258
[TBL] [Abstract][Full Text] [Related]
40. Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium.
Liu W; Xie S; Chen X; Rao X; Ren H; Hu B; Yin T; Xiang Y; Ren J
Int J Clin Exp Pathol; 2014; 7(2):709-15. PubMed ID: 24551293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
